Hundreds of women have filed Shower-to-Shower lawsuits and other ovarian cancer cases involving Johnson & Johnson’s talc-based powders. These plaintiffs claim that the company failed to warn consumers that long-term use these products for feminine hygiene purposes might contribute to the development of the disease.
The nationwide law firm of Bernstein Liebhard LLP is offering free legal reviews to women who may have developed ovarian cancer due to their use of Shower-to-Shower and other talc-based powders made by Johnson & Johnson. To discuss your case with one of our attorneys, please contact our office at (888) 994-5118.
A Motion for Transfer has been filed with the U.S. Judicial Panel on Multidistrict Litigation that seeks the transfer of all federally-filed talcum powder lawsuits involving Johnson & Johnson to a single U.S. District Court for the purposes of coordinated pretrial proceedings. The July 15th petition notes that at least 11 claims are pending in federal courts, all of which put forth similar allegations regarding the potential for Shower-to-Shower and other Johnson & Johnson talc-based products to contribute to the development of ovarian cancer. The petitioner also asks that the JPML establish the proposed MDL in the U.S. District Court, Southern District of Illinois. Read More
Shower-to-Shower is an adult body powder developed by Johnson & Johnson. For decades, the product was marketed via the tagline “A Sprinkle a Day Helps Keep Odor Away.” In 2012, Johnson & Johnsons sold Shower-to-Shower to Valeant Consumer Products, a division of Valeant Pharmaceuticals North America.
Valeant continues to market Shower-to-Shower as a solution to feminine hygiene concerns, and the website is dominated by photos of women. The advertising copy urges all-over use of the product:
Since the 1970s, at least 20 studies have suggested that long-term use of talc for feminine hygiene purposes increased the risk of ovarian cancer by about 33%. Some of the most recent include:
While the overall odds of a woman developing ovarian cancer is about 1 in 70, these and other studies indicate that the odds rise to 1 in 53 among women who regularly and repeatedly apply talc-based powders like Baby Powder to their genitals.
In 2016, two ovarian cancer cases involving Shower-to-Shower and other Johnson & Johnson talcum powders went to trial in Missouri state court. The first concluded in February, when the company was ordered to pay $72 million in compensatory and punitive to the family of a woman who had died of the disease. In April, another ovarian cancer victim was awarded $55 million in total damages. According to their lawsuits, both women had used Johnson & Johnson’s talc products as part of their daily feminine hygiene routine for several decades. Read More
According to Bloomberg News, evidence presented at trial included internal documents suggesting that Johnson & Johnson was aware of the possible link between talcum powder and ovarian cancer by the 1970s. Yet it continued to aggressively market Shower-to-Shower to women.
You may be entitled to compensation if you or a woman you care about developed ovarian cancer that might be related to the long-term, genital use of Shower-to-Shower and other talcum powder products. To learn more about filing Shower-to-Shower lawsuit, please call (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.